新医学
新醫學
신의학
NEW CHINESE MEDICINE
2014年
2期
95-98
,共4页
马晋%段金海%邹俊涛%汪洋
馬晉%段金海%鄒俊濤%汪洋
마진%단금해%추준도%왕양
阿尔茨海默病%β-淀粉样蛋白%老年斑%Morris 水迷宫行为学测试%肿瘤坏死因子-α
阿爾茨海默病%β-澱粉樣蛋白%老年斑%Morris 水迷宮行為學測試%腫瘤壞死因子-α
아이자해묵병%β-정분양단백%노년반%Morris 수미궁행위학측시%종류배사인자-α
Alzheimer’s Disease%β-amyloid protein%Senile plaque%Morris water maze behavior test%TNF-α
目的:初步探讨人源化抗Aβ抗体对APP/PS1转基因鼠被动免疫治疗效果。方法选取36只APP/PS1转基因鼠,随机分为3组,每组各12只,分别予腹腔注射人源化抗Aβ抗体、鼠源性单克隆抗体、磷酸盐缓冲液(PBS),观察3组小鼠脑内淀粉样斑块积聚情况,测试其学习记忆能力,同时检测血清及脑内TNF-α含量。结果人源化抗Aβ抗体组、鼠源性单克隆抗体组小鼠空间辨别学习记忆能力均优于PBS对照组(P<0.05),人源化抗Aβ抗体组与鼠源性单克隆抗体组间比较差异无统计学意义(P>0.05);治疗后人源化抗Aβ抗体组与鼠源性单克隆抗体组小鼠大脑皮质、海马区棕色斑块沉积明显形态变小、数量变少、范围分散。人源化抗Aβ抗体组与鼠源性单克隆抗体组脑内TNF-α含量均较PBS对照组明显减少(P<0.05)。结论人源化抗Aβ抗体治疗转基因小鼠后明显改善其学习记忆能力,同时使其脑内TNF-α含量减少。
目的:初步探討人源化抗Aβ抗體對APP/PS1轉基因鼠被動免疫治療效果。方法選取36隻APP/PS1轉基因鼠,隨機分為3組,每組各12隻,分彆予腹腔註射人源化抗Aβ抗體、鼠源性單剋隆抗體、燐痠鹽緩遲液(PBS),觀察3組小鼠腦內澱粉樣斑塊積聚情況,測試其學習記憶能力,同時檢測血清及腦內TNF-α含量。結果人源化抗Aβ抗體組、鼠源性單剋隆抗體組小鼠空間辨彆學習記憶能力均優于PBS對照組(P<0.05),人源化抗Aβ抗體組與鼠源性單剋隆抗體組間比較差異無統計學意義(P>0.05);治療後人源化抗Aβ抗體組與鼠源性單剋隆抗體組小鼠大腦皮質、海馬區棕色斑塊沉積明顯形態變小、數量變少、範圍分散。人源化抗Aβ抗體組與鼠源性單剋隆抗體組腦內TNF-α含量均較PBS對照組明顯減少(P<0.05)。結論人源化抗Aβ抗體治療轉基因小鼠後明顯改善其學習記憶能力,同時使其腦內TNF-α含量減少。
목적:초보탐토인원화항Aβ항체대APP/PS1전기인서피동면역치료효과。방법선취36지APP/PS1전기인서,수궤분위3조,매조각12지,분별여복강주사인원화항Aβ항체、서원성단극륭항체、린산염완충액(PBS),관찰3조소서뇌내정분양반괴적취정황,측시기학습기억능력,동시검측혈청급뇌내TNF-α함량。결과인원화항Aβ항체조、서원성단극륭항체조소서공간변별학습기억능력균우우PBS대조조(P<0.05),인원화항Aβ항체조여서원성단극륭항체조간비교차이무통계학의의(P>0.05);치료후인원화항Aβ항체조여서원성단극륭항체조소서대뇌피질、해마구종색반괴침적명현형태변소、수량변소、범위분산。인원화항Aβ항체조여서원성단극륭항체조뇌내TNF-α함량균교PBS대조조명현감소(P<0.05)。결론인원화항Aβ항체치료전기인소서후명현개선기학습기억능력,동시사기뇌내TNF-α함량감소。
Objective To preliminarily explore the effect of passive immunity treatment for APP/PS1 transgenic mice with humanization anti-amyloid-βantibodies.Method Thirty-six APP/PS1 transgenic mice were selected and randomly divided into 3 groups.Experimental group(n=1 2)was intraperitoneal injected with humanization anti-amyloid-βantibodies,positive control group was intraperitoneal injected with monoclonal an-tibody,negative control group was intraperitoneal injected with PBS.The accumulation of the amyloid plaques in the brain and the ability of learning and memory were observed.The levels of TNF-αin serum and brain were detected.Result The mice’s ability of learning and memory in space identification of experimental group and positive control group,were statistically better than that of negative control group (P<0.05).However, there is no statistically difference between experimental group and positive control group (P>0.05).With the treatment of humanization anti-amyloid-βantibodies and monoclonal antibody ,the brown plaque deposition in mice’s brain cortex and hippocampus were obviously smaller,with less number and dispersive range.The levels of TNF-αin brain in experimental group and positive control group decreased significantly when compared with negative control group (P<0.05).Conclusion For transgenic mice,humanization anti-amyloid-βantibod-ies could obviously improve their learning and memory ability,and increase the level of TNF-αin brain.